menu
    • menu

    Company profile for Genelux

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Genelux is leading the way in understanding and translating the science behind oncolytic viruses. We have developed a robust drug discovery capability, and are building a pipeline of innovative oncolytic virus-based cancer therapies and collaborates with leading medical and academic research institutions, clinicians and scientists to replicate, validate, and maximize the potential applications and impact of its discoveries.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GeneluxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3030 Bunker Hill Street San Diego, CA 92109 United States
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.genelux.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Genelux Corp Joins Fireside Chat At Piper Sandler Healthcare Conf
    Genelux Corp Joins Fireside Chat At Piper Sandler Healthcare Conf

    26 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/26/3195094/0/en/Genelux-Corporation-to-Participate-in-a-Fireside-Chat-at-Piper-Sandler-37th-Annual-Healthcare-Conference.html

    GLOBENEWSWIRE
    26 Nov 2025
    Share Share
    Genelux Corp. Unveils Q3 2025 Financials & Business Updates
    Genelux Corp. Unveils Q3 2025 Financials & Business Updates

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3182008/0/en/Genelux-Corporation-Reports-Third-Quarter-2025-Financial-Results-and-Provides-General-Business-Updates.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Genelux Corporation Joins Chat at H.C. Wainwright Conference
    Genelux Corporation Joins Chat at H.C. Wainwright Conference

    02 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/02/3143123/0/en/Genelux-Corporation-to-Participate-in-a-Fireside-Chat-at-H-C-Wainwright-Global-Investment-Conference.html

    GLOBENEWSWIRE
    02 Sep 2025
    Share Share
    Genelux Corporation Reports Q2 2025 Financials, Business Update
    Genelux Corporation Reports Q2 2025 Financials, Business Update

    07 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/07/3129750/0/en/Genelux-Corporation-Reports-Second-Quarter-2025-Financial-Results-and-Provides-General-Business-Updates.html

    GLOBENEWSWIRE
    07 Aug 2025
    Share Share
    Genelux names Eric as General Counsel & Chief Compliance Officer
    Genelux names Eric as General Counsel & Chief Compliance Officer

    07 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/07/3110897/0/en/Genelux-Corporation-Announces-Appointment-of-Eric-Groen-as-General-Counsel-Corporate-Secretary-Chief-Compliance-Officer-and-Head-of-Business-Development.html

    GLOBENEWSWIRE
    07 Jul 2025
    Share Share
    Genelux Corporation Reports Q1 2025 Financial Results and Busines
    Genelux Corporation Reports Q1 2025 Financial Results and Busines

    06 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/06/3075559/0/en/Genelux-Corporation-Reports-First-Quarter-2025-Financial-Results-and-Provides-General-Business-Updates.html

    GLOBENEWSWIRE
    06 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search